XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
ASSETS    
Cash and cash equivalents $ 343,826 $ 454,030
Grant funds receivable 89,895 28,074
Prepaid expenses and other current assets 12,420 62,275
Total current assets 446,141 544,379
Property and equipment, net 38,484 54,828
Deposits 11,010 11,010
Total assets 495,635 610,217
Current liabilities:    
Accounts payable 118,131 75,607
Accrued expenses (Note 6) 613,411 294,240
Total current liabilities 731,542 369,847
Commitments (Note 7)
Stockholders’ equity (deficiency):    
Common stock, $.001 par value: Authorized shares – 600,000,000 and 300,000,000 at September 30, 2017 and December 31, 2016, respectively Issued and outstanding shares – 70,913,900 and 55,235,233 at September 30, 2017 and December 31, 2016, respectively 70,914 55,235
Additional paid-in capital 35,155,343 34,914,963
Accumulated deficit (37,400,607) (35,746,628)
Total stockholders’ equity (deficiency) (235,907) 240,370
Total liabilities and stockholders’ equity 495,635 610,217
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 76,095 76,095
Series C Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 882,348 940,705
Series D Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock $ 980,000